All Work

Chris Lange

ConAgra Investors Cheer Private Brands Exit

ConAgra Foods reported its fiscal fourth-quarter financial results Tuesday before the markets opened and announced the divestiture of its Private Brands unit.

Chris Lange · 11 years ago

What Celgene Now Means for Juno

Celgene and Juno Therapeutics are coming together in a global collaboration for the development and commercialization of immunotherapies.

Chris Lange · 11 years ago

Digicel Files for IPO

Digicel Group has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).

Chris Lange · 11 years ago

Sarepta Takes Its Foot off the Gas

Sarepta Therapeutics announces the completion of the rolling submission of a New Drug Application to the FDA for eteplirsen.

Chris Lange · 11 years ago

Big Synthesis Energy Contract Numbers, but Little Impact

Synthesis Energy Systems has announced a definitive share purchase and investment agreement with Rui Feng Enterprises and a separate operation and management agreement with Shandong Saikong Automation.

Chris Lange · 11 years ago

What to Expect From ConAgra Earnings

ConAgra Foods is scheduled to release its fiscal fourth-quarter financial results Tuesday before the markets open.

Chris Lange · 11 years ago

Serious Valuation Concerns Arise in JPMorgan

JPMorgan commands a strong position in the financial sector, and it is a staple of many portfolios. However, one key analyst sees a rougher time ahead for this mega bank.

Chris Lange · 11 years ago

5 Key Earnings for the Week Ahead

24/7 Wall St. has put together a preview ConAgra, Apollo Education and some of the other companies reporting their quarterly results this week.

Chris Lange · 11 years ago

5 Unusual Movers in the Past Week

Facebook and Williams Companies were among S&P 500 stocks that made significant moves this past week.

Chris Lange · 11 years ago

Can Major Airlines Take Off Again?

Over the past 52 weeks, the airline industry climbed to new highs as fuel prices fell to a post-recession low. However, the industry rally might not be over yet.

Chris Lange · 11 years ago

Can Celladon Weather the Storm?

Celladon is continuing to seek out a merger partner, and at the same time, it is not pursuing the further development of its existing programs.

Chris Lange · 11 years ago